Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigation of the dopamine system in frontotemporal dementia.

Trial Profile

Investigation of the dopamine system in frontotemporal dementia.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2018

At a glance

  • Drugs Tolcapone (Primary)
  • Indications Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jun 2016 Planned End Date changed from 1 Oct 2014 to 1 Oct 2016.
    • 14 Jun 2016 Status changed from completed to active, no longer recruiting.
    • 08 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top